tiprankstipranks
Trending News
More News >
Immunome (IMNM)
NASDAQ:IMNM
US Market
Advertisement

Immunome (IMNM) Ownership - Who Owns Immunome?

Compare
324 Followers

Immunome (IMNM) Ownership Overview

1.57%23.77%46.65%10.55%17.46%
46.65% Other Institutional Investors
10.55% ETFs
17.46% Public Companies and
Individual Investors
The ownership structure of Immunome (IMNM) stock is a mix of institutional, retail, and individual investors. Approximately 80.97% of the company’s stock is owned by Institutional Investors, 1.57% is owned by Insiders, and 17.46% is owned by Public Companies and Individual Investors.
The ownership structure of Immunome (IMNM) stock is a mix of institutional, retail, and individual investors. Approximately 70.42% of the company’s stock is owned by Institutional Investors, 1.57% is owned by Insiders, and 10.55% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 03, 2025
xxxxxxxxxxxxx
$46900
Mar 26, 2025
xxxxxxxxxxxxx
$60684
Mar 26, 2025
xxxxxxxxxxxxx
$999459
Mar 25, 2025
xxxxxxxxxxxxx
$57470

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2025
xxxxxxxxxxxxx
$95427
Jun 30, 2025
xxxxxxxxxxxxx
$2055300
Jun 30, 2025
xxxxxxxxxxxxx
$15425565
Jun 30, 2025
xxxxxxxxxxxxx
$28087953

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,170,396Institution4.79%42,871,671
3,416,792Institution3.93%35,124,622
3,076,700Institution3.53%31,628,476
3,055,989Institution3.51%31,415,567
3,020,210Institution3.47%31,047,759
2,851,542Institution3.28%29,313,852
2,376,141Institution2.73%24,426,729
2,278,596Institution2.62%23,423,967
1,658,663Institution1.91%17,051,056
1,526,901Institution1.75%15,696,542

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,416,792Institution3.93%35,124,622
3,076,700Institution3.53%31,628,476
2,851,542Institution3.28%29,313,852
2,376,141Institution2.73%24,426,729
2,278,596Institution2.62%23,423,967
1,526,901Institution1.75%15,696,542
818,181Institution0.94%8,410,901
804,799Institution0.92%8,273,334
781,967Institution0.90%8,038,621
704,518Institution0.81%7,242,445

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,193,827Institution2.52%23,079,060
1,768,849Institution2.03%18,183,768
968,733Institution1.11%9,629,206
881,239Institution1.01%9,270,634
642,557Institution0.74%6,605,486
382,192Institution0.44%3,798,988
351,626Institution0.40%3,699,106
214,955Institution0.25%2,261,327
191,296Institution0.22%1,901,482
169,199Institution0.19%1,681,838

FAQ

Who Owns Immunome (IMNM)?
According to the latest TipRanks data, approximately 46.65% of the company's stock is held by institutional investors, 1.57% is held by insiders, and 17.46% is held by retail investors.
    What percentage of Immunome (IMNM) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 46.65% of Immunome (IMNM) stock is held by institutional investors.
      What percentage of Immunome (IMNM) stock is held by retail investors?
      According to the latest TipRanks data, approximately 17.46% of Immunome (IMNM) stock is held by retail investors.
        Who owns the most shares of Immunome (IMNM)?
        Vanguard owns the most shares of Immunome (IMNM).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis